Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Niraparib plus bevacizumab versus niraparib alone for pla... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
0
Authors
Mansoor Mirza
18 more
Mansoor Mirza
•
Elisabeth Lundqvist
16 more
•
Johanna Mäenpää
Published
August 29, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1016/s1470-2045(19)30515-7
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1016/s1470-2045(19)30515-7
License
publisher-specific-oa
